These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31884574)

  • 21. Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study.
    De Carlo V; Grancini B; Cassina N; Casati L; Piccoli E; Vismara M; Gobbo D; Zanaschi R; Lupo S; Olivieri S; Dell'Osso B
    Int Clin Psychopharmacol; 2023 May; 38(3):160-168. PubMed ID: 36729532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis.
    Nolt VD; Kibler AV; Wilkening GL; Fabian TJ
    Paediatr Drugs; 2017 Apr; 19(2):139-146. PubMed ID: 28074349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.
    Hsu C; Ried LD; Bengtson MA; Garman PM; McConkey JR; Rahnavard F
    J Am Pharm Assoc (2003); 2008; 48(3):393-400. PubMed ID: 18595825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics.
    Santini I; Stratta P; D'Onofrio S; De Lauretis I; Santarelli V; Pacitti F; Rossi A
    Riv Psichiatr; 2016; 51(1):37-42. PubMed ID: 27030348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics.
    Sanyal S; Lyu N; Calarge C; Rowan PJ; Aparasu RR; Abughosh S; Chen H
    J Child Adolesc Psychopharmacol; 2023 Sep; 33(7):269-278. PubMed ID: 37676976
    [No Abstract]   [Full Text] [Related]  

  • 27. Metabolic profile of first and second generation antipsychotics among Chinese patients.
    Lee E; Chow LY; Leung CM
    Psychiatry Res; 2011 Feb; 185(3):456-8. PubMed ID: 20554016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
    Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
    J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.
    Lee NY; Kim SH; Jung DC; Kim EY; Yu HY; Sung KH; Kang UG; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1273-8. PubMed ID: 21513765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.
    Devlin AM; Ngai YF; Ronsley R; Panagiotopoulos C
    Transl Psychiatry; 2012 Jan; 2(1):e71. PubMed ID: 22832733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of prescription of antipsychotics in Qatar.
    Ouanes S; Becetti I; Ghuloum S; Hammoudeh S; Shehata M; Ghabrash H; Yehya A; Al-Lawati H; Al-Fakhri N; Iram H; Ajmal N; Eltorki Y; Al-Amin H
    PLoS One; 2020; 15(11):e0241986. PubMed ID: 33166337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics.
    Panagiotopoulos C; Ronsley R; Kuzeljevic B; Davidson J
    Can J Psychiatry; 2012 Jan; 57(1):34-44. PubMed ID: 22296966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.
    Henderson DC
    J Clin Psychiatry; 2008 Feb; 69(2):e04. PubMed ID: 18363448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
    Wu YH; Lai CY; Chang YS
    Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.
    Misiak B; Frydecka D; Łaczmański Ł; Ślęzak R; Kiejna A
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1433-41. PubMed ID: 25291992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.
    Ferrara M; Umlauf A; Sanders C; Meyer JM; Allen McCutchan J; Duarte N; Hampton Atkinson J; Grant I; Ellis RJ;
    Psychiatry Res; 2014 Aug; 218(1-2):201-8. PubMed ID: 24794030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet and cardiometabolic side effects in children treated with second-generation antipsychotics.
    Barker MK; Sable CM; Montgomery SE; Chow L; Green TJ; Panagiotopoulos C; Devlin AM
    Clin Nutr ESPEN; 2018 Feb; 23():205-211. PubMed ID: 29460800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.
    Fiedorowicz JG; Palagummi NM; Forman-Hoffman VL; Miller DD; Haynes WG
    Ann Clin Psychiatry; 2008; 20(3):131-7. PubMed ID: 18633739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.
    Correll CU; Frederickson AM; Kane JM; Manu P
    J Clin Psychiatry; 2006 Apr; 67(4):575-83. PubMed ID: 16669722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.